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The choroid plexus epithelium (CPE) is located in the ventricular system of the brain,
where it secretes the majority of the cerebrospinal fluid (CSF) that fills the ventricular
system and surrounds the central nervous system. The CPE is a highly vascularized single
layer of cuboidal cells with an unsurpassed transepithelial water and solute transport rate.
Several members of the slc4a family of bicarbonate transporters are expressed in the CPE.
In the basolateral membrane the electroneutral Na+ dependent Cl−/HCO3− exchanger,
NCBE (slc4a10) is expressed. In the luminal membrane, the electrogenic Na+:HCO3−
cotransporter, NBCe2 (slc4a5) is expressed. The electroneutral Na+:HCO3− cotransporter,
NBCn1 (slc4a7 ), has been located in both membranes. In addition to the bicarbonate
transporters, the Na+/H+ exchanger, NHE1 (slc9a1), is located in the luminal membrane of
the CPE. Genetically modified mice targeting slc4a2, slc4a5, slc4a7, slc4a10, and slc9a1
have been generated. Deletion of slc4a5, 7 or 10, or slc9a1 has numerous impacts
on CP function and structure in these mice. Removal of the transporters affects brain
ventricle size (slc4a5 and slc4a10) and intracellular pH regulation (slc4a7 and slc4a10).
In some instances, removal of the proteins from the CPE (slc4a5, 7, and 10) causes
changes in abundance and localization of non-target transporters known to be involved
in pH regulation and CSF secretion. The focus of this review is to combine the insights
gathered from these knockout mice to highlight the impact of slc4 gene deletion on the
CSF production and intracellular pH regulation resulting from the deletion of slc4a5, 7
and 10, and slc9a1. Furthermore, the review contains a comparison of the described
human mutations of these genes to the findings in the knockout studies. Finally, the
future perspective of utilizing these proteins as potential targets for the treatment of CSF
disorders will be discussed.
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INTRODUCTION
Membrane transporters of the slc4 and slc9 family are expressed in
many tissues mediating numerous functions including acid-base
regulation and movement of large amounts of fluid and solutes.
The Na+ dependent acid-base transporters, slc4a5, −7, −10,
and−11, and slc9a1 are all expressed in the choroid plexus epithe-
lium (CPE) (Praetorius et al., 2004a; Bouzinova et al., 2005;
Damkier et al., 2007; Damkier and Praetorius, 2012) where they,
in addition to intra- and extracellular acid-base regulation, are
involved in cerebrospinal fluid (CSF) secretion.
Over the last decadesmany genetically modifiedmousemodels
have been developed targeting these transporters. The pheno-
types reported in some of these mice highlight the significance of
the transporters in the CPE. The objective of the current review
is to extract the insights gathered from these studies to give an
overview of the important role of Na+ dependent pH regulators
in the CPE. Removal of a protein by genetic modification in ani-
mal models gives an indication of the consequences of genetic
mutations in human. It does, however, not necessarily provide
insight into the physiological role of the transporter in the tis-
sue. An important lesson from the studies of knockout mice is
the compensatory mechanisms that take place when removing a
protein by genetic modification. This makes it difficult to extrap-
olate the role of the isolated protein in the tissue. This role is
potentially not the same as that observed when inhibiting the pro-
tein pharmacologically. In this review we will attempt to extract
the data from the knockoutmice and compare these to the human
mutations and pharmacological studies of these transporters in
the CPE and finally relate to studies of the same transporters in
other epithelia.
CHOROID PLEXUS STRUCTURE AND MORPHOLOGY
The CPE constitutes a specialized and important part of the
blood-CSF barrier (BCSFB). This barrier consists of endothelium,
endothelial basement membrane, interstitial space with sparse
connective tissue, subepithelial basement membrane and a single
layer of cuboidal epithelial cells (Figure 1).
During fetal development, certain areas of the brain ependyma
become highly vascularized (Zagorska-Swiezy et al., 2008) and
form the specialized secretory epithelium, protruding into the
ventricles. The CPE is found in all four ventricles of the brain,
forming branched, villous structures.
In contrast to the vasculature that constitutes the tight blood-
brain barrier, the capillaries of the CPE are fenestrated and thus
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the fluid in the interstitial space resembles plasma ultra-filtrate.
In fact, molecules as large as ferritin (∼450kDa) are able to pass
across the endothelium (Hurley et al., 1981). The permeability
of the CP vasculature may be subject to regulation, as vascu-
lar endothelial growth factor secreted by CP epithelial cells both
maintain (Kamba et al., 2006; Maharaj et al., 2008) and induce
(Esser et al., 1998) the formation of fenestrations in endothelium.
The barrier function of the BCSFB is therefore mainly gen-
erated through the tightness of the CPE, as the single layer of
cells is sealed by tight junctions (Wolburg et al., 2001). This is
in contrast to the blood-brain barrier where the barrier func-
tion is made up of the tight junctions in the endothelial cells of
the vascular wall (Figure 3). The basolateral membrane of the
CPE is highly convoluted and intertwining, allowing for rapid
transport of solutes to and from the cytoplasm. The apical mem-
brane of the epithelium is covered with microvilli, enlarging the
cell surface area and facilitating the role of the epithelium as a
highly secretory organ and regulator of CSF composition. The
CPE cells also contain clusters of cilia (Mestres et al., 2011), crit-
ical for maintaining the flow and possibly the secretion of CSF
(Narita et al., 2010).
CEREBROSPINAL FLUID SECRETION
The main role of the CPE is to produce CSF. The majority
(approximately 80%) of the CSF is secreted by the CPE while
the remaining 20% is derived from the brain interstitial fluid
(Redzic et al., 2005). The adult human CPE secretes approxi-
mately 0.5 L CSF/day at a rate of approximately 0.2–0.4ml/min/g
tissue. The total CSF volume surrounding the brain and spinal
cord is estimated to be about 150ml in adults and is dis-
tributed in the cranial and spinal subarachnoid spaces (125ml)
and in the brain ventricles (25ml) (Sakka et al., 2011). The
[Na+]CSF in rabbit was measured to be 149mM compared
to 148mM in plasma. The [HCO3−]CSF in rabbit was esti-
mated to 22mM compared to 25mM in plasma (Davson and
FIGURE 1 | AQP1 and NCBE in the choroid plexus. Confocal micrograph
of mouse choroid plexus stained with anti-AQP1 antibodies (red) and
anti-NCBE antibodies (green). AQP1-specific labeling is seen in the luminal
membrane (arrows). NCBE-specific labeling is seen in the basolateral
membrane and with high abundance also in the basal labyrinth between
adjoining cells. BL: basolateral. Lumen: 4th ventricle lumen. This illustration
was published by Damkier et al. (2012) (Damkier and Praetorius, 2012).
Segal, 1996). The composition of the ions in the CSF differs
from that predicted for a plasma ultrafiltrate as Na+, Mg++,
and HCO3− concentrations are higher and K+ and Ca++ are
lower in CSF (Ames et al., 1964). Thus, the CSF is actively
secreted by the CPE and the concentrations of these ions stay
relatively constant despite fluctuations in plasma (Husted and
Reed, 1977; Murphy et al., 1986). Finally, CSF is slightly hyper-
tonic compared to plasma (approximately 5mM CSF positive,
Davson and Purvis, 1954) which would not be expected from an
ultra-filtrate.
CSF secretion by the CPE is unlike in other secretory epithe-
lia driven by an osmotic gradient generated by the transcellular
movement of Na+ from blood through CPE to the CSF (Wright,
1972). In other secretory epithelia, Cl− drives secretion. The
osmotic gradient drives water to be moved from plasma to the
CSF. Unlike most other secretory epithelia the Na, K ATPase is
located in the luminal membrane of the CPE (Figure 2). The
Na, K ATPase is pivotal for creating the Na+ gradient that
drives Na+ import across the basolateral membrane (Ames et al.,
1965). Na+ enters the cell presumably via the Na+ dependent
HCO3− co-transporter, NCBE. The movement of water through
the CPE is mainly believed to be mediated by AQP1 located in
the luminal membrane and to a smaller degree in the basolateral
membrane (Figure 1) (Nielsen et al., 1993; Praetorius, 2007).
FIGURE 2 | Transporters in the choroid plexus. Schematic presentation
of two choroid plexus epithelial cells residing on a vascular bed (red to
blue). The basolateral membrane is characterized by lateral infoldings near
the basement membrane. The wider luminal membrane is connected with
tight junctions (red line). Top and bottom: Membrane transporters in the
luminal and basolateral membrane (see text for details). AQP1, Aquaporin-1;
NBCe2, Electrogenic Na+ HCO3− co-transporter; NBCn1, Electroneutral
Na+ HCO3− co-transporter; NHE1, Na+/H+ exchanger; NaBC1,
Na+:B(OH)−4 co-transporter; NCBE, Na
+ dependent Cl−/HCO−3 exchanger.
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FIGURE 3 | Schematic presentation of the circulation of CSF and the
barriers of the brain. CSF is mainly produced by the choroid plexus (1, CP)
in all four ventricles of the brain 2. The CSF is drained via narrow foramina 3
into the subarachnoid space (SAS, 4) between the pia mater and the dura
mater. The CSF is continuously returned to the circulation mainly via the
arachnoid granulations 5. Some CSF is also generated by the interstitial
fluid (ISF) arising from the blood vessels of the BBB and the ependyma.
The blood brain barrier (BBB) is made from the endothelial cells in the brain
capillaries. Permeability for solutes to the brain is limited by this barrier that
is kept very constricted by tight junctions. The blood-CSF barrier (BCSFB)
consists of relatively leaky capillaries but the tight junctions of the epithelial
cells restrict the permeability to the CSF.
Some water-movement could also occur through a paracellular
route, e.g., via claudin-2 (Rosenthal et al., 2010).
REGULATION OF pH IN BRAIN AND CSF
Acid-base balance in the extracellular fluid surrounding the brain
is a prerequisite for optimal brain function, as the neurons
are very sensitive to changes in pH (Balestrino and Somjen,
1988). The blood brain barrier (BBB) is virtually impermeable
to HCO3− and H+ (De Bersaques and Leusen, 1954; Siesjo and
Ponten, 1966) while CO2 readily diffuses across the BBB into
the brain parenchyma (Ponten, 1964; Geiser et al., 1996). CO2
from the blood is in equilibrium with the CO2 in the CSF, and
numerous studies have shown that changes in arterial pCO2 affect
CSF pCO2, pH, and ventilation (Pappenheimer et al., 1965; Fencl
et al., 1966; Loeschcke and Sugioka, 1969; Andrews et al., 1994).
Furthermore, it is known that neuronal excitability is enhanced by
increases in brain pH, and decreased when brain pH is lowered
(Balestrino and Somjen, 1988). A pioneering study showed that
rat pups exposed to hyperthermia developed respiratory alkalo-
sis and febrile seizures (Schuchmann et al., 2006). Seizures have
long been known to be halted by inhalation of CO2 (Pollock et al.,
1949). CSF is practically devoid of proteins, meaning that the
non-HCO3− buffering power is almost non-existing, and, as the
BBB is impermeable to HCO3− and H+, the brain must rely on
other mechanisms for regulating its acid-base balance in the face
of changes in plasma pCO2. Apart from the ventilatory response
upon changes in CSF/extracellular acid-base status, it is believed
that the CPE plays a role in the regulation of CSF pH by secre-
tion and absorption of acid/base equivalents. In 1967, Kazemi
showed an almost identical increase in arterial blood pCO2 and
CSF pCO2 in dogs after 1 h of 10% CO2 inhalation. In the dogs
that hyperventilated, similar drops in pCO2 were observed in
blood and CSF. The ensuing changes in CSF pH were of the
same magnitude as the changes in blood pH in both experiments
after 1 h. However, 6 h into the experiment, CSF pH had returned
toward its resting value, whereas no similar compensation was
observed in the blood (Kazemi et al., 1967). This indicates that
CSF pH is somehow protected against long-term acid-base distur-
bances. Furthermore, CO2-stimulated increases in CSF [HCO3−]
are accompanied by an increase in CSF [Na+] (Nattie, 1980),
indicating that buffering of CSF pH is Na+-dependent. As the
CPE expresses a range of Na+ dependent acid-base transporters
(Figure 2) it is therefore well equipped for protecting CSF pH
against the effects of changes in blood pCO2.
BASOLATERAL Na+ DEPENDENT ACID-BASE
TRANSPORTERS
The Na+ dependent Cl−/HCO3− exchanger, NCBE (slc4a10), is
expressed in the basolateral membrane of the CPE (Figures 1,
2) (Praetorius et al., 2004a), where it performs Na+-dependent
Cl−/HCO3− exchange (Wang et al., 2000; Damkier et al., 2010a),
although the precise mode of action differs between expression
systems (Parker et al., 2008). In all cases NCBEmediates the trans-
port of Na+ and HCO3− into the cell. In rat and human the
electroneutral Na+:HCO3− co-transporter, NBCn1 is also found
in the basolateral membrane of the CPE (Praetorius and Nielsen,
2006). The Na+ dependent Cl−/HCO3− exchanger (slc4a8) is
expressed in the basolateral membrane of the rat fetus (Chen
et al., 2008a), however, in adult rats the expression is absent
suggesting a role of NDCBE in choroid plexus development.
SLC4a10
The Na+ HCO3−-importer, NCBE, was originally cloned and
functionally characterized in 2000 (Wang et al., 2000). NCBE is
primarily located in the CNS (Giffard et al., 2003).
A knockout mouse model of the slc4a10 gene was generated by
Jacobs et al (Jacobs et al., 2008) by introducing a targeted deletion
of exon 12, encoding the first trans-membrane region of NCBE,
causing a frame-shift and a premature stop codon in exon 13.
Disrupting NCBE has profound structural implications in the
CPE; microvilli are reduced, the intercellular space of the CPE
is enlarged (Jacobs et al., 2008), and interestingly, the polar-
ization of NHE1 changes from the apical to the basolateral
membrane of the cells (Damkier et al., 2009). These changes
may be caused by the redistribution of ezrin (Damkier and
Praetorius, 2012), an anchoring protein important for e.g., cell
shape and the organization of membrane proteins (Jiang et al.,
2013), including the binding of NHE1 to the actin cytoskele-
ton (Denker et al., 2000). The complete mechanism and conse-
quences of these changes, however, remains to be fully elucidated.
NCBE is central for the secretory function of the CPE. NCBE
knockout mice displayed 80% smaller brain ventricle volumes
(Jacobs et al., 2008), most likely due to a decrease in CSF pro-
duction, and thereby supporting the hypothesis of NCBE as
the bottleneck for basolateral Na+-loading in the CPE. Loss of
NCBE was also found to decrease expression levels of Na/K-
ATPase and AQP1 in the CP (Damkier and Praetorius, 2012),
further supporting a greatly reduced CSF production capacity.
In comparison, disruption of AQP1 alone only lowers CSF pro-
duction by 25% (Oshio et al., 2003). In isolated CPE cells from
the knockout mice there is an 80% reduction in the Na+ and
HCO3−-dependent pHi recovery rate indicating a role of NCBE
www.frontiersin.org October 2013 | Volume 4 | Article 304 | 3
Christensen et al. Acid/base transporters in the choroid plexus
in CPE pHi regulation and perhaps movement of HCO3− from
blood to CSF. As in the NBCe2 knockout studies the compen-
satory changes in the proteins important for CSF secretion and
pH regulation the interpretation of the role of NCBE in the CSF
secretion and warrants the need for further studies to highlight
this task.
Expression of NCBE is also found in the retina (Hilgen et al.,
2012). Visual impairment, in terms of decreased contrast sensi-
tivity, retinal displacement, and atypical electro-retinograms were
reported in mice with NCBE disruption.
As mentioned earlier, neuronal firing activity alters both
intra- and extracellular pH, which in turn modifies neuronal
excitability (Chesler and Kaila, 1992). NCBE is also widely
expressed in the neurons of the hippocampus, cortex and cere-
bellum (Chen et al., 2008b), and is presumably involved in
the pH homeostasis of the brain (Chen et al., 2007). Its role
in regulating pH with regard to modifying neuronal excitabil-
ity, is therefore of particular interest. Indeed, NCBE knockout
mice held a higher threshold to pentylenetrazol, with longer
latency of seizure onsets as well as decreased seizure severity
(Jacobs et al., 2008).
Human studies involving NCBE are also mainly associated
with changes in neuronal excitability. In a patient with par-
tial, complex epilepsy and cognitive dysfunction, genetic analysis
revealed a translocation with a break point between exon 2 and
3 of SLC4A10 (Gurnett et al., 2008). The epilepsy in this patient
is in contrast to what was seen in the knockout mice that seem
to be protected against seizures. Another case study of a patient
with generalized epilepsy and speech retardation, found a dele-
tion in the 2q24.2 region, which includes the SLC4A10 locus
(Krepischi et al., 2010). Finally, statistical analysis of a large cohort
of patients with autism, revealed a single deletion of exon 1
of the SLC4A10 in a pair of monozygous autistic twins (Sebat
et al., 2007). The twins were, however, not further described,
and whether they also suffered from epilepsy is therefore
unknown.
LUMINAL Na+ DEPENDENT ACID-BASE TRANSPORTERS
The slc4a5 gene product, NBCe2, is expressed in the luminal
membrane of the CPE (Figure 2; Bouzinova et al., 2005). NBCe2
mediates the transport of three HCO3− together with one Na+
from the cell to the CSF. This stoichiometry suggests a role
of NBCe2 in CSF pH regulation (Millar and Brown, 2008).
In mouse, and in some cases in humans, NBCn1 (slc4a7) is
expressed in the luminal membrane (Praetorius and Nielsen,
2006). The apparent discrepancy in localization of this protein
between species could indicate that the protein in CPE is most
likely involved in protecting the cell from intracellular acidifica-
tion rather than in secretion of CSF as the direction of transport
regardless of the membrane expression is most likely inwards.
The Na+ Borate transporter (slc4a11) is similarly expressed in the
luminal membrane of CPE (Damkier et al., 2007). This trans-
porter was recently shown to transport Na+ in exchange for
H+ suggesting a similar role as the Na+/H+ exchanger, NHE1,
in the luminal membrane. Finally, NHE1 (slc9a1) is present
in the luminal membrane of the CPE (Damkier et al., 2009).
The localization of NHE1 indicates that this protein, similar
to NBCe2, could be an important mechanism for regulating
CSF pH.
In addition to these transporters the CPE expresses numerous
other transporters involved in the secretion of solutes and nutri-
ents. These are outside the scope of this review but are reviewed
elsewhere (Damkier et al., 2010b; Ho et al., 2012).
SLC4a5
The slc4a5 gene product, NBCe2 (also known as NBC4), is
an electrogenic sodium bicarbonate co-transporter. It exists in
at least two variants, NBCe2a (1137-residue polypeptide), and
NBCe2c (1074-residue polypeptide). In choroid plexus a novel
variant, NBCe2g, was reported (Fukuda et al., 2013). The variants
differ in their C-termini (Pushkin et al., 2000). When expressed
in mammalian cells, NBCe2 mediates DIDS-sensitive sodium-
bicarbonate co-transport (Virkki et al., 2002; Romero et al.,
2004). In CPE, NBCe2 mediates the efflux of one Na+ together
with three HCO3− from the cell into the CSF (Millar and Brown,
2008). When expressed in Xenopus laevis oocytes, NBCe2 shows
a 2:1 HCO3−:Na+ stoichiometry (Virkki et al., 2002). Thus, the
stoichiometry of NBCe2 appears to be cell specific. In addition to
the choroid plexus, NBCe2 has been localized in kidney, liver, and
gastrointestinal tract although the precise subcellular localization
of the protein is not known (Sassani et al., 2002; Xu et al., 2003).
Currently, there are three published slc4a5 mouse models.
The first slc4a5 knockout mouse was generated by infecting
embryonic stem cells with a retroviral gene trap vector, that
integrated upstream of exon 15 (Kao et al., 2011) inserting
a stop codon that prevented further translation. In the pre-
dicted protein sequence this should truncate the protein after 650
amino acids after the predicted fifth trans-membrane domain.
The second mouse model was generated by deleting the sev-
enth coding exon of the slc4a5 gene. This deletion lead to the
loss of the N-terminal part of the protein and a truncation
due to a frame-shift in the open reading frame of the tran-
script before the putative first trans-membrane domain (Groger
et al., 2012). The third model was generated by deleting exon
13, which removed codons 474–563 and created a frame-shift
mutation. By creating the frame-shift, the potential for trans-
lation of the 500 amino acid membrane-spanning domains of
the protein was eliminated (Chen et al., 2012). Multiple defects
in the central nervous system were observed in the slc4a5 defi-
cient mice. The defects include decreased volume of lateral brain
ventricles, decreased intracranial pressure, changes in CPE cell
morphology, and alterations of the subcellular distribution of
slc4a10 and Na, K ATPase subunits (Kao et al., 2011). The
mice displayed changes in CSF composition (decreased [HCO3−]
and increased [K+]) as well as decreased seizure susceptibility
upon administration of the pro-convulsant drug pentylenetetra-
zol. The data from these mice indicate that NBCe2 is impor-
tant for CSF secretion and pH regulation; however, the com-
pensatory changes in the localization of transporters equally
imperative for CSF secretion and pH regulation make it dif-
ficult to determine the specific role of NBCe2. In addition to
the CPE phenotype, vision was also affected due to retinal
detachment and optical nerve changes in these mice (Kao et al.,
2011).
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The second slc4a5 knockout mouse was found to be hyperten-
sive and presents with metabolic acidosis (Groger et al., 2012).
This phenotype was attributed to the renal expression of NBCe2.
Investigations of the levels of proteins expressed in the kidney
revealed an increase in other bicarbonate transporters includ-
ing AE1, Pendrin, and slc4a7. Proteins involved in Na+ handling
in the kidney were not investigated. The brain ventricle volume
was not reduced in this knockout mouse (Groger et al., 2012)
highlighting a discrepancy between the two mouse models.
In the third slc4a5 knockout mouse the duodenum was inves-
tigated. There was no apparent difference in HCO3− secre-
tion in the knockout mouse compared to wild-type suggesting
that NBCe2 does not play an important role in duodenum
(Chen et al., 2012). Several studies have linked polymorphisms
in SLC4A5 to salt-sensitive hypertension in humans (Barkley
et al., 2004; Carey et al., 2012). It is not known whether
these polymorphisms also associate to CSF disorders or visual
defects.
SLC4a7
The electroneutral sodium bicarbonate co-transporter, NBCn1
(also known as NBC3), was originally cloned in three variants
from rat smooth muscle cells (Choi et al., 2000). Since then, more
variants have been cloned and now 32 slc4a7 products encoding
full-length transporters exist (Liu et al., 2013; Parker and Boron,
2013). NBCn1 functions as an electroneutral Na+:HCO3− co-
transporter with a stoichiometry of 1:1 and is, compared to other
Na+:HCO3− transporters, less sensitive to DIDS (Choi et al.,
2000).
NBCn1 has been localized in many tissues including CPE
(Praetorius et al., 2004a), renal thick ascending limb (TAL)
(Odgaard et al., 2004) and medullary collecting duct epithelial
cells(Praetorius et al., 2004b), vascular smooth muscle cells and
endothelial cells from a broad range of blood vessels(Boedtkjer
et al., 2008). The function of NBCn1 has been investigated in
various cell types. In kidney, NBCn1 expression increases in the
basolateral membrane of TAL following chronic metabolic aci-
dosis (Odgaard et al., 2004). Apart from being a cellular pH
regulator NBCn1may be involved inmaintainingmedullary tran-
scellular NH+4 -shuttling by maintaining a favorable TAL pHi.
In duodenal villus enterocytes NBCn1 has a prominent role as
a major pHi regulatory mechanism (Praetorius et al., 2001; Chen
et al., 2012).
NBCn1 is expressed by the CPE in rodents and humans
(Praetorius et al., 2004a; Damkier et al., 2006, 2007), but the
subcellular distribution is not fully clarified. In rat and human
(Praetorius et al., 2004a; Praetorius and Nielsen, 2006), NBCn1
antibodies localize the transporter to the basolateral domain of
the CPE. In human and some mice strains, however, NBCn1
is found in the luminal membrane domain (Damkier and
Praetorius, 2012). Considering the ions transported by NBCn1,
it is plausible that NBCn1 is important in pH-regulation of the
CPE. The HCO3− dependent pHi-regulation at steady-state level
and after cellular acidification has been investigated in order to
describe the function of the Na+:HCO3− transporters in pH-
regulation in the CPE cell (Bouzinova et al., 2005). The study
shows a partially DIDS-sensitive Na+ dependent HCO3− uptake
in rat CPE cells. The DIDS-insensitive component may be medi-
ated by NBCn1.
Currently, there are two known slc4a7 mouse models. The first
knockout mouse was generated using a targeting vector causing a
deletion of parts of exon 5 which lead to a truncation of the pro-
tein after 137 amino acids (Bok et al., 2003). The second mouse
model was generated using a gene trap vector integrated 434 bases
upstream of the MEAD start codon of slc4a7 (Boedtkjer et al.,
2011).
The first slc4a7 knockout mice showed characteristics of Usher
syndrome type II which includes moderate to severe, progressive
hearing loss and normal vestibular function. The major conse-
quence of NBCn1 deletion within the inner ear is the selective
loss of inner and outer hair cells as well as the loss of support-
ing cells from the hook region. A disruption in the electroneutral
sodium bicarbonate flux mediated by NBCn1 cause a disruption
of the pH sensitive K+ secretion into the endolymph. In the sec-
ondmouse, vascular smooth muscle cells of the NBCn1 knockout
mouse had a lower steady state pHi, resulting in a disruption in
artery function and blood pressure regulation (Boedtkjer et al.,
2011).
Furthermore, genome wide association studies have indicated
that single nucleotide polymorphisms (SNPs) in the 3′ UTR
of NBCn1 are linked to susceptibility to breast cancer (Ahmed
et al., 2009). It is still speculative in what way NBCn1 con-
tributes to the etiology of breast cancer (Parker and Boron,
2013). Additionally SNPs NBCn1 was linked to blood pres-
sure dysregulation (International Consortium for Blood Pressure
Genome-Wide Association et al., 2011).
SLC4a11
Slc4a11 was cloned in 2001 (Parker et al., 2001) and originally
characterized as a 2 Na+/B(OH)−4 co-transporter and, in the
absence of borate, as an electrogenic Na+/2OH− co-transporter
(Park et al., 2004). A more recent characterization suggests that
slc4a11 has EIPA-sensitive Na+:OH−(H+) permeability and does
not transport either HCO3− or borate (Ogando et al., 2013)
Two slc4a11 knockout mice have been described. The first was
generated by a retroviral gene trap vector integrated upstream of
exon 2 of slc4a11 containing a stop codon (Lopez et al., 2009). The
second was generated using a targeting vector causing fusion of
exon 10 to beta-galactosidase and deletion of exons 11–18 which
leads to truncation of the gene before the first predicted trans-
membrane domain (Groger et al., 2010).
Both mice have been thoroughly investigated with respect to
their corneal phenotype. The two mice seemingly differ in respect
to the severity of the phenotype. The first mouse displayed no
corneal changes but showed a collapsed membranous labyrinth
that encases the sensory epithelia as well as disruption of the
neural transduction at receptor level. The second mouse showed
thickening of the endothelial cell layer, Descemets membrane,
stroma, and the endothelial cell layer of the cornea as well as
increased [Na+] in corneal stroma. The mice potentially differ
because the first study was performed in youngmice and the latter
in 12 months old mice. In the second study, the renal phenotype
was also studied and the mice presented with polyuria, loss of
NaCl in the urine and hypoosmolar urine.
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Slc4a11 is localized in the luminal membrane of human CPE
(Damkier et al., 2007). The physiological role of slc4a11 in the
CPE is not known. The recent functional study of slc4a11 as
an EIPA-sensitive Na+/H+ exchanger indicates a role as an acid
extruder. In NHE1 knockout mice, however, there is no evidence
of Na+ dependent pHi recovery in the absence of CO2/HCO3−
in isolated CPE (Damkier and Praetorius, 2012) suggesting that
NHE1 is the only active Na+/H+ exchanger and that slc4a11 does
not play any role for pHi regulation at least in the normal phys-
iological range. However, in Ncbe knockout mice where NHE1
is basolateral a luminal HCO3− independent Na+, base-importer
becomes active in the absence of NHE2-4 expression. It cannot
be ruled out that slc4a11 protein is involved in this transport
phenomenon.
In humans, mutations in SLC4A11 are associated with congen-
ital hereditary endothelial dystrophy (CHED), corneal dystrophy
and perceptive deafness (Harboyan syndrome) and late onset
Fuchs endothelial corneal dystrophy (FECD) (Desir et al., 2007).
SLC9a1
NHE1 is an amiloride-sensitive Na+/H+-exchanger transport-
ing one Na+ into the cell in exchange for one H+ and thus
the protein has a function similar to the inwardly directed Na+
dependent HCO3− co-transporters, which is net acid extrusion.
NHE1 is ubiquitously expressed in all mammalian cells (Sardet
et al., 1988). In epithelial cells, NHE1 is usually expressed in
the basolateral membrane, as seen in certain renal tubular cells
(Biemesderfer et al., 1992).
NHE1 is involved in acid extrusion in e.g., neurons (Yao et al.,
1999), renal TALs (Good et al., 2004), parotid glands (Evans et al.,
1999), choroid plexus (Damkier et al., 2009), and vasculature
(Boedtkjer et al., 2012a). The activity of NHE1 is also a critical
factor in regulation of cell motility and cell volume (Boedtkjer
et al., 2012b).
Currently, there are two known slc9a1 mouse models. One
model was made by targeting the sixth and seventh trans-
membrane-spanning domains of slc9a1 (Bell et al., 1999) while
the other, the slow-wave epilepsy (swe) mutant arose as a sponta-
neous mutation (Cox et al., 1997). There are phenotypic similar-
ities between the targeted Nhe1−/− mutant and the swe mutant.
The mice show ataxic gait at 2 weeks of age and increased neu-
ronal excitability in neonates. The mutants showed increased
mortality even before weaning and a postmortem appearance
suggestive of death by convulsive seizures. NHE1 mRNA in CPE
has been shown in human, rat and pig (Kalaria et al., 1998).
It was first suggested that NHE1 was expressed in the basolat-
eral membrane of CPE cells as it is in other epithelial cells. This
was supported by studies showing a 50% decrease in CSF secre-
tion when the NHE1 inhibitor, amiloride, was given intravenously
(Davson and Segal, 1970). NHE1 was later immunolocalized to
the luminal membrane domain in mouse and human CPE and
functionally found to be the only active HCO3− -independent,
Na+-dependent acid extruder in mouse CPE (Damkier et al.,
2009).
The significance of NHE1 expression in CPE is not fully under-
stood. The subcellular location in the luminal membrane could
indicate that it may function as a pHi regulator, although the
expression level seems to be quite low. In NCBE knockout mice,
NHE1 translocates to the basolateral membrane and may in this
situation function as a Na+ loader to sustain the lowered CSF
secretion (Damkier et al., 2009).
No studies have shown a correlation between NHE1 disrup-
tion and human disease, but it is clear that NHE1 is an important
pharmacological target in some pathophysiological situations
as ischemic heart disease and human breast cancer (Malo and
Fliegel, 2006).
CHOROID PLEXUS AS TARGET FOR PHARMACOLOGICAL
TREATMENT
Delivery of drugs from blood to the brain is greatly limited by the
tightness of the barriers in the brain, the BBB and the BCSFB. The
CPE is the key component in the BCSFB. The physical tightness of
the BCSFB is accomplished by the tight junctions connecting the
epithelial cells, whereas the tightness of the larger BBB is made by
the tight junctions between the endothelial cells in the brain cap-
illaries (Figure 3; Reese and Karnovsky, 1967). In addition to the
physical tightness, both the BCSFB and especially the BBB con-
tain ATP binding cassette (ABC) transporters that actively rid the
brain of xenobiotics thereby further preventing drug-delivery to
the brain. Therapeutic strategies have targeted these transporters
to increase delivery to the brain through the BBB (Hartz and
Bauer, 2010). In some cases, injections of therapeutics directly
into the subarachnoid space (intrathecal administration) are used
as targeted treatments of diseases in the brain such as tumors and
infections (Varelas et al., 2008; Serwer and James, 2012).
As the physical barrier function of the BCSFB is not in the
vasculature but rather in the CPE cells the proteins in the baso-
lateral membrane of CPE could potentially be targeted in therapy
to inhibit CPE functions, e.g., secretion and pH regulation of
CSF. Given the dramatic effects on CSF secretion of knocking
out NCBE, this protein is an obvious drug target for reducing
CSF secretion. Direct neuronal side effects of inhibition of NCBE
may not be relevant since the protein within the CNS would
be protected by the BBB and thereby only the CPE would be
targeted. However, brain pH could be affected through equili-
bration with a possibly altered CSF pH. The brain is covered
by the rigid skull which necessitates a tight regulation of vol-
ume and thereby intracranial pressure (ICP) in order to avoid
damage to the brain tissue. Sudden increases in ICP can in
the worst case lead to fatal incarceration. Overall, increases in
volume inside the skull can be placed within the three “com-
partments” of the brain; the brain tissue (tumors), the blood
(hemorrhage, swelling following ischemia or trauma) or the CSF
(hydrocephalus). According to the Monro-Kelli doctrine, any
increase in one of these compartments needs to be balanced by
a decrease in another (Mokri, 2001). Decreasing CSF secretion
during the acute stages of increases in ICP could be extremely
beneficial for the patient outcome.
Regulation of CSF pH and thereby brain pH is essential for
normal brain function and is similarly important for inhibition of
seizures. Both the NCBE and NBCe2 knockout mice seem to have
a higher seizure threshold than wild type. It is known that lower-
ing of pH during a seizure causes an activation of the acid sensing
Na+ channel, ASIC1a, leading to an inhibition of neuronal firing
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and thereby cessation of the seizure (Ziemann et al., 2008). The
loss of a bicarbonate transporter in the NBCe2 and NCBE knock-
out mice most likely causes a decrease in CSF-pH which could
potentially be protective for the brain. In addition to inhalation
of CO2 in the acute stages of a seizure these proteins could be
potential targets in the long-term treatment of seizure disorders
by acutely lowering CSF pH and thereby brain pH.
CONCLUSIONS
The study of choroid plexus physiology by use of knockout mice
targeting the Na+ dependent acid-base transporters of the slc4
and slc9 families have so far highlighted many aspects of the
significance of these transporters in CSF secretion and pH reg-
ulation. Further studies are warranted for highlighting the role of
slc4a11 and slc9a1 in choroid plexus biology.
The studies highlight the importance of epithelial transporters
in vivo, however the findings in genetically modified mice include
the compensatory mechanisms that take place during fetal devel-
opment and early life, and call for a general need for caution when
interpreting these data. The genetic removal of some transporters,
such as NCBE and NBCe2 leads to restructuring of the entire
epithelium. This is interesting from a cell structure point-of-view
but when investigating the particular protein of interest these
compensatory changes could also completely change cell function
and are thus not specific to removal of one protein. The compen-
satory changes could potentially be minimized by either creating
an inducible knockout mouse allowing the mouse to fully develop
before inducing the deletion, by generating mice that carry a
specific mutation that blocks the NBC action, or by intraventric-
ular installation of siRNA targeting the gene product. These kinds
of studies introduce other complicating factors including the suc-
cess rate of knockdown. This emphasizes the need for selective
inhibitors both for studying the transporters of the slc4 family but
also for use in the pharmacological targeting of the transporters
in disease.
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